National Grid Transco PLC National Grid PLC (NEW) American Depositary Shares vs Vir Biotechnology Inc. Common Stock — how do they compare? National Grid Transco PLC National Grid PLC (NEW) American Depositary Shares trades at $79.27 (market cap $78.99B), while Vir Biotechnology Inc. Common Stock trades at $10.5 (market cap $1.76B). The key difference: National Grid Transco PLC National Grid PLC (NEW) American Depositary Shares is far larger — about 44.9× Vir Biotechnology Inc. Common Stock's market cap, and National Grid Transco PLC National Grid PLC (NEW) American Depositary Shares pays a 4.13% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals.
| NGG | VIR | |
|---|---|---|
Market Cap | $78.99B | $1.76B |
Volume | 740,402 | 2,764,948 |
Sector | Utilities | Health |
52-Week High | $93.93 | $11.78 |
52-Week Low | $73.54 | $5.12 |
Enterprise Value | $137.22B | $1.32B |
Dividend Yield | 4.13% | — |
Typical Hold Time | — | 0 Days |
Signals from Pluang's Aura AI — not financial advice
National Grid (NGG) trades at $78.23, up 1.44% on the day, with a market cap of approximately $48.3 billion. The stock shows stable technicals near its consensus price target of $79.25. Fundamentally, it maintains strong profitability with an 18.32% net income margin and has beaten EPS estimates in recent quarters. Recent news highlights institutional buying and a focus on grid innovation, including AI adoption.
Outlook is cautiously positive with upside to the high target of $85.50, supported by earnings momentum and strategic investments. Risks include high debt levels and regulatory pressures. Analyst consensus leans buy (55%), but hold ratings reflect concerns over capital intensity and macroeconomic sensitivity.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
National Grid plc is a British utility company that owns and operates electricity and gas transmission networks in Great Britain, and through its US Regulated business, operates electricity and gas transmission and distribution networks serving customers in New York and Massachusetts. Its shares trade on the NYSE as American Depositary Shares under the ticker NGG.
Read more on NGG →Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →